PMDI Financials: Psychemedics Corp AI Analysis

Home

Stock

PMDI

Financials

PMDI Financial

Psychemedics Corp

$1.6

11.88%

$0.17

As of today:Mar 26, 12:09:36 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$1.43

Open

$1.53

Day's Range

$1.53 - $1.6

52 week range

$1.37 - $2.4

Volume

1.9K

Avg.Volume

3.1K

Dividend yield

0.00%

EPS (TTM)

-0.32

Market Cap

$9.7M

What is PMDI?

Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. The company is headquartered in Acton, Massachusetts and currently employs 101 full-time employees. The firm provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The firm customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. The company provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The firm markets its corporate drug testing services through its own sales force, distributors, and partners. The company markets its home drug testing service, PDT-90, through the Internet.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

PMDI Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	19	19	22	25	24	21
Revenue Growth (YoY)	-14%	-14%	-12%	4%	14%	-43%
Cost of Revenue	12	12	13	15	14	16
Gross Profit	7	7	8	9	10	4
Selling, General & Admin	8	8	10	9	8	9
Research & Development	0	0	1	1	1	1
Operating Expenses	8	8	11	10	10	10
Other Non Operating Income (Expenses)	0	0	0	0	--	--
Pretax Income	-1	-1	-3	-1	0	-6
Income Tax Expense	0	0	0	0	0	-2
Net Income	-1	-1	-4	-1	0	-3
Net Income Growth	-75%	-75%	300%	--	-100%	-400%
Shares Outstanding (Diluted)	5.98	5.86	5.74	5.63	5.55	5.52
Shares Change (YoY)	3%	2%	2%	1%	1%	0%
EPS (Diluted)	-0.31	-0.31	-0.72	-0.19	-0.12	-0.7
EPS Growth	-56%	-56%	281%	57.99%	-83%	-350%
Free Cash Flow	0	0	-1	4	0	-5
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	36.84%	36.84%	36.36%	36%	41.66%	19.04%
Operating Margin	-5.26%	-5.26%	-9.09%	-4%	0%	-28.57%
Profit Margin	-5.26%	-5.26%	-18.18%	-4%	0%	-14.28%
Free Cash Flow Margin	0%	0%	-4.54%	16%	0%	-23.8%
EBITDA	0	0	-1	1	2	-4
EBITDA Margin	0%	0%	-4.54%	4%	8.33%	-19.04%
D&A For EBITDA	1	1	1	2	2	2
EBIT	-1	-1	-2	-1	0	-6
EBIT Margin	-5.26%	-5.26%	-9.09%	-4%	0%	-28.57%
Effective Tax Rate	0%	0%	0%	0%	0%	33.33%

Follow-Up Questions

What are Psychemedics Corp's key financial statements?



According to the latest financial statement (Form-10K), Psychemedics Corp has a total asset of $8, Net loss of $-1

What are the key financial ratios for PMDI?



Psychemedics Corp's Current ratio is 2.66, has a Net margin is -5.26, sales per share of $3.23.

How is Psychemedics Corp's revenue broken down by segment or geography?



Psychemedics Corp largest revenue segment is Testing, at a revenue of 18,661,000 in the most earnings release.For geography, United States is the primary market for Psychemedics Corp, at a revenue of 21,216,000.

Is Psychemedics Corp profitable?



no, according to the latest financial statements, Psychemedics Corp has a net loss of $-1

Does Psychemedics Corp have any liabilities?



yes, Psychemedics Corp has liability of 3

How many outstanding shares for Psychemedics Corp?



Psychemedics Corp has a total outstanding shares of 6.11

Psychemedics Corp (PMDI) Financial

PMDI Stock Price Chart